Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
14
2023
Navigating the Pricing Regulation for Pharmaceuticals and Medical Devices in India – Part B [Podcast] Nishith Desai Associates
Jul
14
2023
Navigating the Pricing Regulation for Pharmaceuticals and Medical Devices in India – Part A Nishith Desai Associates
Jul
14
2023
FDA Releases Final Guidance on Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements Sheppard, Mullin, Richter & Hampton LLP
Jul
14
2023
CMS Releases Proposed Remedy for 340 B-Acquired Drugs Purchased in Cys 2018–2022 McDermott Will & Emery
Jul
14
2023
Litigation Minute: Is PFAS Litigation Heating Up? K&L Gates
Jul
14
2023
FDA, USDA, DHS Publish Interim Review on Strengthening Food and Ag Security Keller and Heckman LLP
Jul
14
2023
FTC and FDA Issue Warnings for THC Edibles in Kids Candy Packaging Norris McLaughlin P.A.
Jul
13
2023
PHMSA Seeks Comment on Initiatives to Modernize the HMR Bergeson & Campbell, P.C.
Jul
13
2023
The 2023 DOJ Health Care Fraud Enforcement (f/k/a “Takedown”): Big Dollars or Clever Packaging? Epstein Becker & Green, P.C.
Jul
13
2023
FDA Releases List of Food Additives No Longer GRAS Keller and Heckman LLP
Jul
13
2023
Domestic Producer of Pea Protein Requests Imposition of Antidumping and Countervailing Duties on Imports From China ArentFox Schiff LLP
Jul
13
2023
CMS Releases Proposed Remedy for 340B-Acquired Drugs Purchased in Cost Years 2018–2022 McDermott Will & Emery
Jul
13
2023
The Ninth Circuit Declares that Ambiguity can be Cured with Back Label Sheppard, Mullin, Richter & Hampton LLP
Jul
13
2023
Highly Legal: Will Congress Legalize Mushrooms Before Marijuana? Bradley Arant Boult Cummings LLP
Jul
12
2023
Connecticut Places Checks on PBM Contracts in Support of 340B Covered Entities Robinson & Cole LLP
Jul
12
2023
First Of Its Kind With More To Follow: NJDEP Settlement Proposal Addresses PFAS Contamination Giordano, Halleran & Ciesla, P.C.
Jul
12
2023
Commercial Cannabis Permit Program and Overlay District Statutorily Exempt Under CEQA Guideline Section 15183 Sheppard, Mullin, Richter & Hampton LLP
Jul
12
2023
Sen. Schumer Calls for FDA Investigation into PRIME’s Energy Drink Caffeine Content and Marketing Tactics Keller and Heckman LLP
Jul
11
2023
USDA Reviews Soybean, Tomato, and Potato Plants Modified Using Genetic Engineering Bergeson & Campbell, P.C.
Jul
11
2023
Unpacking Averages: Searching for Bias in Word Embeddings Trained on FDA Regulatory Documents Epstein Becker & Green, P.C.
Jul
11
2023
European Parliamentary Committee Rejects Proposed Lower Limits for Nitrite and Nitrite additives; Favors Total Ban Keller and Heckman LLP
Jul
10
2023
Assessing the 2023 Congressional Agenda Greenberg Traurig, LLP
Jul
10
2023
Healthcare Preview for the Week of: JULY 10, 2023 McDermott Will & Emery
Jul
10
2023
Payment Cuts and Program Changes: CMS Issues Calendar Year 2024 Home Health Prospective Payment System Proposed Rule Nelson Mullins
Jul
10
2023
FDA and FTC Issue Six Warning Letters for Delta-8 THC Copycat Snacks Keller and Heckman LLP
Jul
8
2023
District of Columbia Cannabis Employment Protections Amendment Act Goes Live July 13 Jackson Lewis P.C.
Jul
7
2023
FDA Publishes Updated List of Priority Guidance Topics Keller and Heckman LLP
Jul
6
2023
There are many headlines today that "nearly half" of our drinking water contains PFAS, but no mentions of Paracelsus, and here's why that matters. Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins